During the year under review, Company continued to advance its innovation on discovering and developing novel pharmaceutical products, for central nervous system ("CNS") disorders using G ...
For the financial year ended March 31, 2025 (“FY25”), the Company reported its highest ever annual profit after tax (“PAT”) at Rs. 1,015 Crores. Total assets under , management (“AUM”) increased to Rs ...
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback